• Latest Posts

Resalis Therapeutics receives €10M to develop obesity and NAFLD treatment

Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

Study of drug to treat porphyria disorders initiated by Disc Medicine

Opinion 11 Jul 2022

Precision medicine: the next big leap for metabolic disorders


Poxel publishes ALD studies